The first oral pill for obstructive sleep apnea could be around the corner after company Apnimed reported positive results ...

The more than $36 million center is hoped to be a “buffer” against supply chain disruptions and improve oversight, said a St.

Loblaw Companies (TSX: L) posted Q2 2025 revenue of $14.67 billion, up 5.2% YoY and 3.8% from the prior quarter. On operations, same-store food sales rose 3.5%, barely ahead of internal food inflation ...

A decision to possibly sell the business, which was poised to become the centerpiece of a restructuring plan, represents a shift in strategy by new company leaders.

Roche Holding AG's H2 2025 earnings show solid growth in pharma revenues but highlight pipeline struggles and U.S. pricing ...

Pharmaceutical companies have been in talks with the U.S. government to figure out how to bring drug prices down after President Trump signed in May an executive order that ties U.S. prices to the ...

Telehealth platform Hims & Hers Health (NYSE:HIMS) shot to the top of stock charts yesterday as shares soared 16% high on no company news. While it is revolutionizing access to healthcare by ...

An NHS surgeon has delivered his 'hot take' on why weight-loss jabs like Wegovy and Mounjaro are causing 'Ozempic babies' to be born.

Mounjaro users on Reddit are complaining of developing 'creepy' and 'saggy' skin on their necks after losing weight on GLP-1 ...

Shopify's moat and vast runway for growth make its prospects highly attractive. Axsome Therapeutics has a robust late-stage pipeline that should lead to important approvals. Others understand that the ...

Loblaw Cos. said revenue and profit rose as same-store traffic, basket size and item count all increased from a year ago. The company also announced a 4-for-1 stock split that it said would be ...

Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares ...